Sharon Hausman-Cohen MD: DNA, Genomics and Dementia Risk

Genomics provides a roadmap for preventing and reversing cognitive decline by identifying modifiable root causes rather than relying on a single genetic marker. While the APOE4 allele significantly increases Alzheimer's risk, it functions within a complex network of factors including mitochondrial health, inflammation, and nutrient metabolism. Personalized medical plans, such as those utilizing the SLUMS assessment and targeted interventions like lion’s mane mushroom for inflammation or specific dietary adjustments, demonstrate that cognitive function can be restored even in high-risk patients. Case studies of individuals like "Mackie" and "Rachel" illustrate that combining genomic insights with lifestyle modifications—such as high-intensity exercise and targeted supplementation—allows for precise, individualized care. Ultimately, DNA is not destiny; it serves as a functional guide for optimizing health span and addressing the underlying mechanisms of chronic neurological conditions.